Developing new treatments for COVID-19
Clinical Development of COVID-19 Therapeutics
This study is looking for new treatments for COVID-19 that are specially designed for people with kidney and liver issues, and it gives patients a chance to join early trials to see how well these new options work for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aligos Therapeutics, INC. NIH-funded |
| Lab location | 1 site (South San Francisco, United States) |
| Project ID | NIH-11063909 on NIH RePORTER |
What this research studies
This research focuses on creating and testing new therapeutic options for COVID-19, particularly targeting patients with renal and hepatic impairments. The project involves several stages, including optimizing drug candidates, conducting preclinical studies, and eventually moving into Phase I clinical trials to assess safety and efficacy. Patients may have the opportunity to participate in early-stage trials that evaluate how well these new treatments work in their specific health conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals with COVID-19 who also have renal or hepatic impairments.
Not a fit: Patients without COVID-19 or those with no renal or hepatic impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective new treatments for COVID-19, particularly for patients with compromised kidney or liver function.
How similar studies have performed: Previous research has shown promise in developing antiviral therapies for COVID-19, making this approach both relevant and potentially impactful.
Where this research is happening
South San Francisco, United States
- Aligos Therapeutics, INC. — South San Francisco, United States (Active)
Researchers
- Principal investigator: Wang, Stanley — Aligos Therapeutics, INC.
- Study coordinator: Wang, Stanley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.